{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:01:27Z","timestamp":1784559687812,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Development Fund of Affiliated Hospital of Xuzhou Medical University","award":["XYFY202312"],"award-info":[{"award-number":["XYFY202312"]}]},{"name":"Huai\u2019an Science and Technology Plan Project","award":["HAB2024013"],"award-info":[{"award-number":["HAB2024013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05283-8","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T10:53:56Z","timestamp":1779706436000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative transcriptomic and single-cell analysis reveals metabolic reprogramming and hexosamine biosynthesis-mediated tumor microenvironment remodeling in prostate cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Jianwei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"7","key":"5283_CR1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, et al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336\u201346. https:\/\/doi.org\/10.1002\/ijc.35278.","journal-title":"Int J Cancer"},{"issue":"12","key":"5283_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"PA Watson","year":"2015","unstructured":"Watson PA, Arora VK, Sawyers CL. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer. 2015;15(12):701\u201311. https:\/\/doi.org\/10.1038\/nrc4016.","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"5283_CR3","doi-asserted-by":"publisher","first-page":"e70030","DOI":"10.1002\/cncr.70030","volume":"131","author":"I Tsung","year":"2025","unstructured":"Tsung I, Yentz SE, Reichert ZR. Controversies in metastatic hormone-sensitive prostate cancer. Cancer. 2025;131(16):e70030. https:\/\/doi.org\/10.1002\/cncr.70030.","journal-title":"Cancer"},{"issue":"5","key":"5283_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"3","key":"5283_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012;21(3):297\u2013308. https:\/\/doi.org\/10.1016\/j.ccr.2012.02.014.","journal-title":"Cancer Cell"},{"issue":"3","key":"5283_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211\u20138. https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001.","journal-title":"Trends Biochem Sci"},{"issue":"9","key":"5283_CR7","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/ijc.29839","volume":"138","author":"GF Weber","year":"2016","unstructured":"Weber GF. Metabolism in cancer metastasis. Int J Cancer. 2016;138(9):2061\u20136. https:\/\/doi.org\/10.1002\/ijc.29839.","journal-title":"Int J Cancer"},{"issue":"17","key":"5283_CR8","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1158\/0008-5472.CAN-21-1392","volume":"81","author":"LA Sena","year":"2021","unstructured":"Sena LA, Denmeade SR. Fatty acid synthesis in prostate cancer: vulnerability or epiphenomenon? Cancer Res. 2021;81(17):4385\u201393. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1392.","journal-title":"Cancer Res"},{"issue":"38","key":"5283_CR9","doi-asserted-by":"publisher","first-page":"61890","DOI":"10.18632\/oncotarget.11301","volume":"7","author":"L Ippolito","year":"2016","unstructured":"Ippolito L, Marini A, Cavallini L, et al. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. Oncotarget. 2016;7(38):61890\u2013904. https:\/\/doi.org\/10.18632\/oncotarget.11301.","journal-title":"Oncotarget"},{"issue":"1","key":"5283_CR10","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/s41467-020-15237-5","volume":"11","author":"B Sch\u00f6pf","year":"2020","unstructured":"Sch\u00f6pf B, Weissensteiner H, Sch\u00e4fer G, et al. OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation. Nat Commun. 2020;11(1):1487. https:\/\/doi.org\/10.1038\/s41467-020-15237-5. Published 2020 Mar 20.","journal-title":"Nat Commun"},{"issue":"6","key":"5283_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/biom15060826","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen Y, Wang J. Role of tumor microenvironment in prostate cancer immunometabolism. Biomolecules. 2025;15(6):826. https:\/\/doi.org\/10.3390\/biom15060826. Published 2025 Jun 6.","journal-title":"Biomolecules"},{"issue":"1","key":"5283_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13578-020-00493-1","volume":"10","author":"EE Bitter","year":"2020","unstructured":"Bitter EE, Townsend MH, Erickson R, Allen C, O\u2019Neill KL. Thymidine kinase 1 through the ages: a comprehensive review. Cell Biosci. 2020;10(1):138. https:\/\/doi.org\/10.1186\/s13578-020-00493-1. Published 2020 Nov 27.","journal-title":"Cell Biosci"},{"key":"5283_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.euros.2024.10.010","volume":"70","author":"TJ Murtola","year":"2024","unstructured":"Murtola TJ, Siltari A, Raittinen P, et al. Elevated levels of serum thymidine kinase 1 predict poor survival for patients with metastatic prostate cancer. Eur Urol Open Sci. 2024;70:135\u201341. https:\/\/doi.org\/10.1016\/j.euros.2024.10.010. Published 2024 Oct 25.","journal-title":"Eur Urol Open Sci"},{"issue":"1","key":"5283_CR14","doi-asserted-by":"publisher","first-page":"30380","DOI":"10.1038\/s41598-025-15375-0","volume":"15","author":"SI Ahmed","year":"2025","unstructured":"Ahmed SI, Mohy AM, Farid HM, Elnaggar GN. Evaluation of thymidine kinase 1 and folate receptor alpha as potential biomarkers in prostate cancer. Sci Rep. 2025;15(1):30380. https:\/\/doi.org\/10.1038\/s41598-025-15375-0.\u00a0Published 2025 Aug 19.","journal-title":"Sci Rep"},{"key":"5283_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2021.01.010","volume":"503","author":"C Lam","year":"2021","unstructured":"Lam C, Low JY, Tran PT, Wang H. The hexosamine biosynthetic pathway and cancer: current knowledge and future therapeutic strategies. Cancer Lett. 2021;503:11\u20138. https:\/\/doi.org\/10.1016\/j.canlet.2021.01.010.","journal-title":"Cancer Lett"},{"issue":"3","key":"5283_CR16","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1021\/acs.chemrev.0c00884","volume":"121","author":"J Ma","year":"2021","unstructured":"Ma J, Wu C, Hart GW. Analytical and biochemical perspectives of protein O-GlcNAcylation. Chem Rev. 2021;121(3):1513\u201381. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00884.","journal-title":"Chem Rev"},{"key":"5283_CR17","doi-asserted-by":"publisher","first-page":"11612","DOI":"10.1038\/ncomms11612","volume":"7","author":"AK Kaushik","year":"2016","unstructured":"Kaushik AK, Shojaie A, Panzitt K, et al. Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer. Nat Commun. 2016;7:11612. https:\/\/doi.org\/10.1038\/ncomms11612.\u00a0Published 2016 May 19","journal-title":"Nat Commun"},{"key":"5283_CR18","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/srep16018","volume":"5","author":"MM Mortensen","year":"2015","unstructured":"Mortensen MM, H\u00f8yer S, Lynnerup AS, et al. Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy. Sci Rep. 2015;5:16018. https:\/\/doi.org\/10.1038\/srep16018.\u00a0Published 2015 Nov 2","journal-title":"Sci Rep"},{"issue":"9","key":"5283_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.ebiom.2015.07.017","volume":"2","author":"H Ross-Adams","year":"2015","unstructured":"Ross-Adams H, Lamb AD, Dunning MJ, et al. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study. EBioMedicine. 2015;2(9):1133\u201344. https:\/\/doi.org\/10.1016\/j.ebiom.2015.07.017. Published 2015 Jul 29.","journal-title":"EBioMedicine"},{"issue":"28","key":"5283_CR20","doi-asserted-by":"publisher","first-page":"e2322203121","DOI":"10.1073\/pnas.2322203121","volume":"121","author":"S Zaidi","year":"2024","unstructured":"Zaidi S, Park J, Chan JM, et al. Single-cell analysis of treatment-resistant prostate cancer: implications of cell state changes for cell surface antigen-targeted therapies. Proc Natl Acad Sci U S A. 2024;121(28):e2322203121. https:\/\/doi.org\/10.1073\/pnas.2322203121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5283_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13(1):816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6. Published 2022 Feb 10.","journal-title":"Nat Commun"},{"issue":"1","key":"5283_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.20517\/cdr.2020.54","volume":"4","author":"P Chetta","year":"2021","unstructured":"Chetta P, Zadra G. Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer. Cancer Drug Resist. 2021;4(1):143\u201362. https:\/\/doi.org\/10.20517\/cdr.2020.54. Published 2021 Mar 19.","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"5283_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12915-019-0671-3","volume":"17","author":"NM Akella","year":"2019","unstructured":"Akella NM, Ciraku L, Reginato MJ. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer. BMC Biol. 2019;17(1):52. https:\/\/doi.org\/10.1186\/s12915-019-0671-3. Published 2019 Jul 4.","journal-title":"BMC Biol"},{"issue":"4","key":"5283_CR24","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3390\/genes14040933","volume":"14","author":"A Paneque","year":"2023","unstructured":"Paneque A, Fortus H, Zheng J, Werlen G, Jacinto E. The hexosamine biosynthesis pathway: regulation and function. Genes (Basel). 2023;14(4):933. https:\/\/doi.org\/10.3390\/genes14040933. Published 2023 Apr 18.","journal-title":"Genes (Basel)"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05283-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05283-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05283-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:02:21Z","timestamp":1784556141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05283-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5283"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05283-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1047"}}